← All drugs Report issue

JNJ-63823539

mAbexperimentalBi-specific

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

TNF-alphaANTAGONIST
TNFA
- Tumor necrosis factor (TNF) ↗
Interleukin 17AANTAGONIST
IL17A
- Interleukin-17A (IL17A) ↗

Chemistry & pharmacology

Multi-specific: Yes (Bi-specific)

Oral

No

Parenteral

No

Topical

No